213 related articles for article (PubMed ID: 36639054)
1. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.
Beasley R; Bruce P; Houghton C; Hatter L
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054
[TBL] [Abstract][Full Text] [Related]
2. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
Krings JG; Beasley R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
[TBL] [Abstract][Full Text] [Related]
3. Beginning to Address an Implementation Gap in Asthma: Clinicians' Views of Prescribing Reliever Budesonide-Formoterol Inhalers and SMART in the United States.
Krings JG; Sekhar TC; Chen V; Blake KV; Sumino K; James AS; Clover AK; Lenze EJ; Brownson RC; Castro M
J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2767-2777. PubMed ID: 37245736
[TBL] [Abstract][Full Text] [Related]
4. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
[TBL] [Abstract][Full Text] [Related]
5. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
Vogelmeier C; Naya I; Ekelund J
Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
[TBL] [Abstract][Full Text] [Related]
6. Budesonide/Formoterol or Budesonide/Albuterol as Anti-Inflammatory Reliever Therapy for Asthma.
Lipworth B; Kuo CR; Stewart K; Chan R
J Allergy Clin Immunol Pract; 2024 Apr; 12(4):889-893. PubMed ID: 38346474
[TBL] [Abstract][Full Text] [Related]
7. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
Aalbers R; Vogelmeier C; Kuna P
Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Budesonide-Formoterol for Maintenance and Reliever Therapy Among Patients With Poorly Controlled Asthma: A Systematic Review and Meta-analysis.
Beasley R; Harrison T; Peterson S; Gustafson P; Hamblin A; Bengtsson T; Fagerås M
JAMA Netw Open; 2022 Mar; 5(3):e220615. PubMed ID: 35230437
[TBL] [Abstract][Full Text] [Related]
9. The management of mild asthma.
O'Byrne PM; Reddel HK; Beasley R
Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
[TBL] [Abstract][Full Text] [Related]
10. Asthma control with ICS-formoterol reliever versus maintenance ICS and SABA reliever therapy: a post hoc analysis of two randomised controlled trials.
Hatter L; Houghton C; Bruce P; Holliday M; Eathorne A; Pavord I; Reddel HK; Hancox RJ; Braithwaite I; Oldfield K; Papi A; Weatherall M; Beasley R;
BMJ Open Respir Res; 2022 Aug; 9(1):. PubMed ID: 36007980
[TBL] [Abstract][Full Text] [Related]
11. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
Korn S; Vogelmeier C; Buhl R
Med Klin (Munich); 2008 May; 103(5):299-310. PubMed ID: 18484216
[TBL] [Abstract][Full Text] [Related]
12. Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma.
McCormack PL; Lyseng-Williamson KA
Drugs; 2007; 67(16):2407-31. PubMed ID: 17983258
[TBL] [Abstract][Full Text] [Related]
13. ICS/formoterol maintenance and reliever therapy: how far beyond asthma?
Beasley R; Bruce P; Hatter L
Thorax; 2023 May; 78(5):430-431. PubMed ID: 36863775
[No Abstract] [Full Text] [Related]
14. Systematic literature review of traits and outcomes reported in randomised controlled trials of asthma with regular dosing of inhaled corticosteroids with short-acting β
Roche N; Yorgancıoğlu A; Cruz AA; Garcia G; Lavoie KL; Abhijith PG; Verma M; Majumdar A; Chatterjee S
Respir Med; 2024 Jan; 221():107478. PubMed ID: 38008385
[TBL] [Abstract][Full Text] [Related]
15. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma.
Krings JG; Gerald JK; Blake KV; Krishnan JA; Reddel HK; Bacharier LB; Dixon AE; Sumino K; Gerald LB; Brownson RC; Persell SD; Clemens CJ; Hiller KM; Castro M; Martinez FD
Am J Respir Crit Care Med; 2023 Feb; 207(4):390-405. PubMed ID: 36538711
[No Abstract] [Full Text] [Related]
16. Satisfaction with single maintenance and reliever therapy or as-needed combined inhaled corticosteroid-formoterol in adults with asthma.
LaCava AF; Gleeson PK; Apter AJ
J Allergy Clin Immunol Pract; 2023 Mar; 11(3):952-954.e1. PubMed ID: 36470520
[No Abstract] [Full Text] [Related]
17. Patterns of Asthma Medication Use in New Zealand After Publication of National Asthma Guidelines.
Hatter L; Eathorne A; Hills T; Bruce P; Houghton C; Weatherall M; Beasley R
J Allergy Clin Immunol Pract; 2023 Sep; 11(9):2757-2764.e5. PubMed ID: 37178765
[TBL] [Abstract][Full Text] [Related]
18. Budesonide-formoterol reliever therapy versus maintenance budesonide plus terbutaline reliever therapy in adults with mild to moderate asthma (PRACTICAL): a 52-week, open-label, multicentre, superiority, randomised controlled trial.
Hardy J; Baggott C; Fingleton J; Reddel HK; Hancox RJ; Harwood M; Corin A; Sparks J; Hall D; Sabbagh D; Mane S; Vohlidkova A; Martindale J; Williams M; Shirtcliffe P; Holliday M; Weatherall M; Beasley R;
Lancet; 2019 Sep; 394(10202):919-928. PubMed ID: 31451207
[TBL] [Abstract][Full Text] [Related]
19. Budesonide/formoterol maintenance and reliever therapy in childhood asthma: Real-world effectiveness and economic assessment.
Yu Y; Cao W; Xiao Y; Li A; Huang H; Liu K; Hu L; Hou X; Xiang L; Wang X
Pediatr Pulmonol; 2023 Dec; 58(12):3406-3415. PubMed ID: 37818789
[TBL] [Abstract][Full Text] [Related]
20. A Practical Guide to Implementing SMART in Asthma Management.
Reddel HK; Bateman ED; Schatz M; Krishnan JA; Cloutier MM
J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S31-S38. PubMed ID: 34666208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]